Exclusive: Lawsuit says Johnson & Johnson was opioid "kingpin" | WHAT REALLY HAPPENED

Exclusive: Lawsuit says Johnson & Johnson was opioid "kingpin"

Johnson & Johnson was the "kingpin" that fueled the country's opioid crisis, serving as a top supplier, seller and lobbyist, according to a state official leading the legal fight against the companies that helped create the crisis.

Why it matters: Purdue Pharma, which makes OxyContin, has been the main target so far in lawsuits. But court documents show attorneys general also are trying to cast a wider net, drawing more attention to J&J's role in the global opioid market.

Driving the news: The first big trial of the opioid epidemic is set to begin in May in Oklahoma. It will set the stage for similar litigation in other states, as well as the consolidated nationwide lawsuit that has been compared to the tobacco litigation of the 1990s.

Oklahoma Attorney General Mike Hunter has asked a state court to publicly release millions of pages of confidential documents that J&J submitted during the discovery phase of the case.
"The public interest in this information is urgent, enduring and overwhelming," he wrote.

Comments

SHARE THIS ARTICLE WITH YOUR SOCIAL MEDIA